The positive effect of PPARγ (and/or its ligands) in bacterial infections, especially its anti-inflammatory effects via inhibition of proinflammatory molecules such as IL-6, TNF-α, IL-1β, and IL-12, has been well documented. The gene discussed is PPARG; the disease is bacterial infectious disease.